Found 6 matching trials
Safety and Efficacy of Simtuzumab (SIM, GS-6624) in Adults With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH) PHASE2 The primary objective of this study is to evaluate whether SIM (formerly re...
Show More Location
Mayo Clinic Hospital
Learn More & Join Trial
Simtuzumab (SIM, GS-6624) in the Treatment of Cirrhosis Due to NASH PHASE2 The primary objective of this study is to evaluate the safety and efficacy ...
Show More Location
Mayo Clinic Hospital
Learn More & Join Trial
Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC) PHASE2 The purpose of this study is to evaluate whether simtuzumab (GS-6624) is ef...
Show More Location
Mayo Clinic Hospital
Learn More & Join Trial
Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) PHASE2 The primary objectives of this study are to determine the effect of simtuzu...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
A Study to Evaluate the Efficacy and Safety of Simtuzumab Combined With Gemcitabine for Metastatic Pancreatic Adenocarcinoma PHASE2 This study will compare the efficacy of simtuzumab (GS-6624) versus placebo...
Show More Location
Birmingham Hematology and Oncology Associates, LLC
Learn More & Join Trial
Efficacy and Safety of Simtuzumab (SIM) With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma PHASE2 The primary objective of this study is to compare the additive efficacy of ...
Show More Location
Clearview Cancer Institute
Learn More & Join Trial